Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Blood Donors and Blood Collection"'
Autor:
Elitza S. Theel, Jane A. O’Halloran, Charles W. Goss, James Brett Case, Adriana M Rauseo, Michael S. Diamond, Jeffrey P. Henderson, Karl G. Hock, Ali H. Ellebedy, Rachel M. Presti, Rita E. Chen, Christopher W Farnsworth
Publikováno v:
Transfusion
medRxiv
article-version (status) pre
article-version (number) 1
medRxiv
article-version (status) pre
article-version (number) 1
Background The COVID‐19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose–response data using the Ortho VITROS IgG as
Autor:
Nancy L Van Buren, Alyssa Ziman, Mary Townsend, Camille M. van Buskirk, Joseph H Cho, Joy Fridey, Maha Al-Ghafry, Beth A. Dy, Rita Reik, James R. Stubbs, Jerome L. Gottschall, Richard R Gammon, Srijana Rajbhandary, George B. Schreiber, Michelle P. Zeller, Mark K. Fung, Hany Kamel
Publikováno v:
Transfusion
Background Although the safety and therapeutic efficacy of COVID‐19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi‐institutional context. Study design and methods Nine blood c
Autor:
Michael J. Ragusa, Mark A. Popovsky, Jan Hartmann, Susan F. Leitman, Elmar R. Burchardt, Zorayr Manukyan
Publikováno v:
Transfusion
Background Source plasma is essential to support the growing demand for plasma‐derived medicinal products. Supply is short, with donor availability further limited by the coronavirus disease 2019 (COVID‐19) pandemic. This study examined whether a
Publikováno v:
Transfusion
Spekman, M L C, Ramondt, S & Sweegers, M G 2021, ' Whole blood donor behavior and availability after deferral : Consequences of a new ferritin monitoring policy ', Transfusion, vol. 61, no. 4, pp. 1112-1121 . https://doi.org/10.1111/trf.16235
Transfusion, 61(4), 1112-1121. Wiley-Blackwell
Spekman, M L C, Ramondt, S & Sweegers, M G 2021, ' Whole blood donor behavior and availability after deferral : Consequences of a new ferritin monitoring policy ', Transfusion, vol. 61, no. 4, pp. 1112-1121 . https://doi.org/10.1111/trf.16235
Transfusion, 61(4), 1112-1121. Wiley-Blackwell
BACKGROUND: To prevent (negative consequences of) temporary deferral due to low hemoglobin, the Dutch national blood service Sanquin introduced a ferritin monitoring policy in 2017. Ferritin is measured after the donation (as opposed to before donati
Autor:
Jed B. Gorlin
Publikováno v:
Transfusion
Background Recently, plateletpheresis donations using a widely used leukoreduction system (LRS) chamber have been associated with T‐cell lymphopenia. However, clinical health consequences of plateletpheresis‐associated lymphopenia are still unkno
Publikováno v:
Transfusion
Background There has been a concern that blood donations can increase the risk of hematological malignancies. We investigated if blood donations increase the risk of developing hematological malignancies, specifically acute lymphoblastic leukemia, ac
Publikováno v:
Transfusion
BACKGROUND Blood products are essential for modern medicine, but managing their collection and supply in the face of fluctuating demands represents a major challenge. As deterministic models based on predicted changes in population have been problema
Autor:
Judith A.E. Somers, Bert Tomson, Marian G.J. van Kraaij, Claudia M Weller, Johanna G van der Bon, Geert W. Haasnoot, Aukje L. Kreuger
Publikováno v:
Transfusion
textabstractBACKGROUND: Patients refractory for platelet transfusions benefit from human leukocyte antigen (HLA)-matched platelet transfusions. Differences in ethnic background of patients and donors could hamper the availability of sufficient number
Publikováno v:
Transfusion
BACKGROUND: Willingness to donate blood depends on personal characteristics, beliefs, and motivations, but also on the cultural context. The aim of this study was to examine whether willingness to donate blood is associated with attitudes toward bloo
Autor:
James Gomez, Kathleen Kelly, Clara Di Germanio, Mahzad Azimpouran, Jonathan Livny, Orsolya Darst, Deborah T. Hung, Rachel Martinelli, Marek Orzechowski, Ralph R. Vassallo, Peijun Ma, Kelsey Hazegh, Michael P. Busch, Eduard Grebe, Shuting Zhang, Graham Simmons, Mars Stone, Larry J. Dumont
Publikováno v:
Transfusion
Background Antibody response duration following severe acute respiratory syndrome coronavirus 2 infection tends to be variable and depends on severity of disease and method of detection. Study design and methods COVID‐19 convalescent plasma from 18